Tag: Moderna

March 18, 2022 Off

Moderna asks FDA’s approval for the 4th Dose Covid-19 Vaccine

By Dino Mustafić

Moderna has submitted a request to the U.S. Food and Drug Administration (FDA) for an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines.

December 10, 2021 Off

Moderna’s Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains

By Dino Mustafić

Moderna today announced the first positive interim data from the Phase 1 study of the Company’s quadrivalent seasonal flu vaccine candidate, mRNA-1010, as it successfully boosted hemagglutination inhibition (HAI) assay geometric mean titers against all strains 29 days after vaccination at all doses tested in both younger and older adults.

June 14, 2021 Off

Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia

By BusinessWire

-Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceuticals company, today announced an agreement to commercialize the Moderna COVID-19 Vaccine and future variant-specific booster candidates in Saudi Arabia.

January 28, 2021 Off

Moderna confirms talking with the US on 100M doses of Cov-19 vaccine

By Dino Mustafić

After the US president’s Biden said the US Federal government would buy 100 million doses of the COVID-19 vaccine from Moderna and another 100 million from Pfizer, Moderna today confirmed that it is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021.

January 25, 2021 Off

Moderna’s vaccine coming to India

By Dino Mustafić

Reuters news agency referred to the Economic Times as saying Monday that Tata Group’s healthcare venture has reportedly started the first discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India.

December 19, 2020 Off

Moderna’s COVID-19 vaccine authorized in U.S.

By BusinessWire

U.S. FDA has authorized mRNA vaccine against COVID-19 for emergency use as total of 200 million doses ordered by the U.S government to date, with an option to purchase up to an additional 300 million doses, while approximately 20 million doses will be delivered by the end of December 2020.